Medical Research

How High Glycemic Index Foods Affect the Heart

The “glycemic index” refers to how much 50 grams of carbohydrates raise blood glucose, depending on the specific food eaten. There is plenty of evidence that a low glycemic index diet helps in prevention and treatment of diabetes. However, there has been limited data on how lower and higher glycemic index foods affect risk for […]

Gene Links Muscle Weakness to Diabetes

People who have type 2 diabetes often have reduced muscle strength, with the ability of the muscles to take up glucose impaired. Researchers have found that a particular gene that normally plays an important role in muscle regeneration is “silenced” in people who have type 2 diabetes. The discovery may lead to future new treatments. […]

Impact of Diabetes & High Blood Pressure on the Aging Heart

Heart disease risk increases with age. Researchers examining the impact of diabetes and high blood pressure on heart disease risk as people grow older found that each measured increase in systolic blood pressure was associated with an increased risk of cardiovascular diseases. The risk was even higher when the patient also had diabetes. Read more

More Support Needed for Patients with Diabetes and Mental Illness

People who have mental illness along with diabetes may struggle when it comes to diabetes self-care and management. The authors of a new study investigating the impact of severe mental illness on adults with diabetes say better interventions and support are needed to help these adults cope with their diabetes needs. Read more

Can a Bacteria Help Treat Diabetes?

Researchers studying gut bacterial were able to isolate four different types of bacteria responsible for either increasing or decreasing the negative impact that can be caused by a typical American diet. The researchers found that patients with diabetes may benefit from adding foods that contain a particular gut bacteria to their diets. Read more

Research into One Body Protein May Help Treat Diabetes, Parkinson’s

Researchers are gaining insight into the biochemical pathway around a protein called Parkin, which plays a key role in maintaining cellular energy. When the Parkin protein misfunctions, it can contribute to the development of Parkinson’s disease, type 2 diabetes, and cancer. Read more

Farxiga Not Effective for COVID-19

A large study that tested whether AstraZeneca’s diabetes drug Farxiga showed benefit in treating patients hospitalized with COVID-19 and at risk of developing serious complications did not meet its goals. Read more

Changes in Waist Size Linked to Heart Issues

Obesity is a major risk factor for both cardiovascular disease and metabolic disorders like diabetes. Both BMI and waist circumference are frequently used as gauges of obesity; however, their relationship to weight loss’s effects on different health outcomes has not been well studied. A recent study adds data linking increases in one’s waist circumference to […]

Will Gene Therapy Transform Diabetes Treatment?

Gene therapy has so far been explored mainly in the treatment of rare diseases, but researchers are now turning to how it may be used to treat type 1 diabetes. Gene therapy advocates say the research could transform type 1 treatment, but the research is in its early stages and many obstacles need to be […]

Type 2 Diabetes Linked to Parkinson’s Disease

Researchers say there is convincing evidence that people with type 2 diabetes have an increased risk of developing Parkinson’s disease. Type 2 diabetes is also linked to faster disease progression in patients who already have Parkinson’s. Read more

Stem Cell Therapy for Type 1 Gets FDA Fast-Track

The FDA has granted fast track designation to VX-880, which is a human stem cell-derived therapy for patients with type 1 diabetes. This islet cell therapy is designed to regulate glucose levels by restoring a patient’s pancreatic islet cell function, including insulin production. Read more

Diabetes Med May Treat Parkinson’s Disease

A clinical trial is being conducted in the United Kingdom to investigate whether the diabetes drug exenatide (Byetta) can be used to treat Parkinson’s Disease. Previous research has found that the risk for Parkinson’s is reduced in people who are treated with exenatide for their type 2 diabetes. Read more

An “Inverse Vaccine” for Type 1?

Researchers are investigating a potential “inverse vaccine” for type 1 diabetes. This vaccine would use the body’s anti-inflammatory dendritic cells to retrain the immune system be less damaging to insulin-producing beta cells. If successful, this could be administered to patients in the early stages of type 1 to slow the disease’s progression. Read more

Zinc Could Provide Insight into Diabetes

Because diabetes damages blood vessels, people with diabetes have an increased risk for blood clots, heart attacks, stroke and vascular dementia. Researchers are examining the role of zinc, which helps the blood clot after injury, in these processes. Read more

Diabetes Among Factors that Cause 2/3 of COVID-19 Hospitalizations

About 64% of adults hospitalized with COVID-19 had one or more of four underlying conditions, researchers say: obesity, diabetes, hypertension, and heart failure. This reinforces other studies which have found these conditions are strongly linked to poor COVID-19 outcomes. Read more

Can Electromagnetic Fields Treat Diabetes?

Electromagnetic fields (EMFs) might be a safe and non-invasive way to manage blood glucose in diabetes, say researchers who examined the effects of EMFs in altering the balance of oxidants and antioxidants in the liver and causing an improvement in the body’s response to insulin. Read more

Anemia and A1c

Glycated hemoglobin (A1c) testing is a standard method of assessing blood glucose levels in people with diabetes. However, researchers are finding that iron deficiency or vitamin B12 deficiency anemia can affect A1c testing results. Read more

Stress, Mood Issues Worse in Younger Patients with Diabetes, Sleep Apnea

Obstructive sleep apnea (OSA), insomnia, and diabetes are often linked and can have an impact on quality of life, worsening the risk for stress and depression. New research suggests the impact is worse on people under the age of sixty-five who experience diabetes and OSA. Read more

More Evidence for Heart Benefits of Empagliflozin

Studies of diabetes drugs empagliflozin and dapagliflozin, both in the SGLT-2 inhibitor class, have shown they help reduce cardiovascular risk for diabetes patients. Now, researchers have found that empagliflozin is beneficial for the heart in people without diabetes as well. Read more

Clinical Trial for Possible New Type 1 Treatment

A clinical trial of a new stem cell-derived pancreatic islet cell treatment for type 1 diabetes, by Vertex Pharmaceuticals, is moving forward. According to Vertex, the therapy, called VX-880, has the potential to restore the body’s ability to normalize blood glucose levels through restoration of pancreatic islet cell function. Read more